Pine Michael Craig Insider Trades

Insider Trading History

Track insider trading activity for Pine Michael Craig. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $169k 13,662 shares
Last Trade
Jan 06, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$122k 5,966 shares
$20.40
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $377k 30,570 shares
Last Trade
Jan 06, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$312k 15,285 shares
$20.40
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $242k 19,628 shares
Last Trade
Jan 06, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$312k 15,285 shares
$20.40
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $518k 42,000 shares
Last Trade
Jan 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$857k 42,000 shares
$20.40
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $621k 50,343 shares
Last Trade
Dec 04, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$825k 45,000 shares
$18.34
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $621k 50,343 shares
Last Trade
Dec 04, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$825k 45,000 shares
$18.34
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $65.9k 5,343 shares
Last Trade
Dec 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$844k 46,000 shares
$18.34
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $65.9k 5,343 shares
Last Trade
Dec 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$825k 45,000 shares
$18.34
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $679k 55,000 shares
Last Trade
Dec 04, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$825k 45,000 shares
$18.34
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $679k 55,000 shares
Last Trade
Dec 04, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$825k 45,000 shares
$18.34
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $566k 45,855 shares
Last Trade
Jun 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$316k 45,855 shares
$6.90
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $185k 15,000 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 22,500 shares
$5.93
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director, Chief Corp Dev.&strat. Officer
Holding Value $1.13M 91,655 shares
Last Trade
Jan 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$299k 91,655 shares
$3.26
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director, Chief Corp Dev.&strat. Officer
Holding Value $12.3k 1,000 shares
Last Trade
Mar 14, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.2k 1,000 shares
$12.21
$12.34
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Chief Corp Dev.&strat. Officer
Holding Value $1.23M 100,000 shares
Last Trade
Jan 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.26M 100,000 shares
$12.62
$12.34

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up